Skip to main content
CORDIS - Forschungsergebnisse der EU
CORDIS

Blood-brain barrier: from molecular mechanisms to intervention strategies

Projektbeschreibung

Ein Zebrafischmodell der Blut-Hirn-Schranke

Die Blut-Hirn-Schranke ist für die Homöostase des Gehirns unerlässlich, da sie den molekularen und zellulären Transport zwischen dem Gehirn und dem Kreislaufsystem steuert. Grundlage hierfür ist die komplexe Kommunikation zwischen den Endothelzellen und anderen Komponenten des neurovaskulären Systems. Das EU-finanzierte Projekt Ctrl-BBB wird die Durchlässigkeit der Blut-Hirn-Schranke anhand eines Modells des Zebrafisches untersuchen, weil dieser von Natur aus transparent ist und sich nicht-invasiven Genanalysen unterziehen kann. Da die Blut-Hirn-Schranke die Wirkstoffabgabe an das zentrale Nervensystem unterbindet, wird entsprechendes Wissen zu ihrer Regulation neue Behandlungswege für verschiedene Erkrankungen eröffnen, darunter Schlaganfall, Multiple Sklerose und Neurodegeneration.

Ziel

Brain endothelial cells (ECs) are endowed with a set of molecular and metabolic adaptations that stringently orchestrate the molecular and cellular transit between the brain and the circulatory system. These adaptations constitute the blood-brain barrier (BBB) and are pivotal to brain homeostasis and protection. Accordingly, BBB dysfunction is a unifying hallmark of many cerebrovascular diseases, including stroke, multiple sclerosis and neurodegeneration. Healing the BBB to treat to the brain is therefore emerging as a powerful therapeutic avenue for a spectrum of human CNS disorders. In addition, through its neuroprotective function, the BBB represents the main obstacle for CNS drug delivery. There is consequently an urgent need to identify methods to control BBB in health and disease. Of pivotal importance, BBB is not genetically hardwired, but instead results from ongoing neurovascular communications taking place between the ECs and the other components of the neurovascular unit. Shedding light on these communications, and raising our understanding to the mechanistic level will undoubtedly yield transformative therapeutic strategies for human brain disorders. A key obstacle in the study of BBB permeability resides in its complex regulation across cells and tissues. This complexity cannot be recapitulated in cell culture experiments. Our laboratory has recently identified and validated the transparent zebrafish as ideally suited to facilitate these studies, by empowering non-invasive genetic analyses of BBB function under normoxia. Together with a conserved BBB genetic instruction program, the zebrafish cerebrovasculature qualifies as a an alternative “miniature BBB model” where neurovascular communication can be studied at an unprecedented pace. Ctrl-BBB will pioneer synergistic approaches between the zebrafish and the mouse model, to bring BBB research in the era of highly parallel genetic approaches and BBB-focused therapeutic strategies for brain disorders.

Gastgebende Einrichtung

UNIVERSITE LIBRE DE BRUXELLES
Netto-EU-Beitrag
€ 2 286 542,50
Adresse
AVENUE FRANKLIN ROOSEVELT 50
1050 Bruxelles / Brussel
Belgien

Auf der Karte ansehen

Region
Région de Bruxelles-Capitale/Brussels Hoofdstedelijk Gewest Région de Bruxelles-Capitale/ Brussels Hoofdstedelijk Gewest Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
€ 2 286 542,50

Begünstigte (1)